DULAGLUTIDE

DULAGLUTIDE was reported 89369 times

These side effects are most commonly reported by patients taking DULAGLUTIDE:

# Side effect Count
0 NAUSEA 10580
1 INJECTION SITE PAIN 10019
2 BLOOD GLUCOSE INCREASED 9960
3 DIARRHOEA 6200
4 VOMITING 5949
5 INCORRECT DOSE ADMINISTERED 5663
6 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3843
7 DRUG INEFFECTIVE 3757
8 WEIGHT DECREASED 3438
9 DECREASED APPETITE 3281
10 EXTRA DOSE ADMINISTERED 3202
11 INJECTION SITE HAEMORRHAGE 3179
12 GLYCOSYLATED HAEMOGLOBIN INCREASED 2979
13 ABDOMINAL PAIN UPPER 2512
14 FATIGUE 2489
15 ABDOMINAL PAIN 2434
16 CONSTIPATION 2412
17 ACCIDENTAL UNDERDOSE 2370
18 PRODUCT DOSE OMISSION ISSUE 2321
19 MALAISE 2100
20 IMPAIRED GASTRIC EMPTYING 2003
21 OFF LABEL USE 1975
22 INJECTION SITE BRUISING 1971
23 ACCIDENTAL OVERDOSE 1897
24 DIZZINESS 1884
25 BLOOD GLUCOSE DECREASED 1854
26 ABDOMINAL DISCOMFORT 1785
27 HEADACHE 1758
28 INJECTION SITE ERYTHEMA 1660
29 DYSPEPSIA 1531
30 PANCREATITIS 1527
31 ILLNESS 1440
32 INJECTION SITE MASS 1435
33 VISUAL IMPAIRMENT 1417
34 DRUG DOSE OMISSION 1353
35 WEIGHT INCREASED 1346
36 FEELING ABNORMAL 1338
37 ASTHENIA 1337
38 INJECTION SITE PRURITUS 1270
39 DEHYDRATION 1224
40 PAIN 1213
41 ABDOMINAL DISTENSION 1182
42 ERUCTATION 1107
43 UNDERDOSE 1079
44 BLOOD GLUCOSE ABNORMAL 1035
45 DYSPNOEA 986
46 OVERDOSE 981
47 FALL 929
48 RASH 915
49 COVID-19 859
50 PRURITUS 849
51 FLATULENCE 848
52 ACUTE KIDNEY INJURY 838
53 INJECTION SITE SWELLING 829
54 GASTROINTESTINAL DISORDER 800
55 DEATH 777
56 PRODUCT DOSE OMISSION 728
57 GASTROOESOPHAGEAL REFLUX DISEASE 724
58 ANXIETY 712
59 PAIN IN EXTREMITY 684
60 ARTHRALGIA 678
61 MEMORY IMPAIRMENT 671
62 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 667
63 PRODUCT STORAGE ERROR 653
64 BACK PAIN 648
65 VISION BLURRED 640
66 CEREBROVASCULAR ACCIDENT 594
67 DEPRESSION 592
68 HYPOGLYCAEMIA 566
69 DRUG HYPERSENSITIVITY 558
70 COUGH 555
71 GASTROINTESTINAL HYPOMOTILITY 553
72 GAIT DISTURBANCE 552
73 INJECTION SITE RASH 529
74 INJURY ASSOCIATED WITH DEVICE 525
75 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 517
76 TREMOR 514
77 URINARY TRACT INFECTION 513
78 DIABETES MELLITUS INADEQUATE CONTROL 495
79 HYPOACUSIS 486
80 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 482
81 BLOOD PRESSURE INCREASED 481
82 INJECTION SITE URTICARIA 480
83 INSOMNIA 480
84 MUSCLE SPASMS 480
85 FEEDING DISORDER 479
86 DIABETIC KETOACIDOSIS 455
87 SOMNOLENCE 448
88 HYPERSENSITIVITY 447
89 HYPERTENSION 440
90 PNEUMONIA 435
91 ALOPECIA 434
92 PERIPHERAL SWELLING 434
93 NASOPHARYNGITIS 433
94 CATARACT 425
95 INTESTINAL OBSTRUCTION 424
96 URTICARIA 417
97 MYOCARDIAL INFARCTION 402
98 INJECTION SITE DISCOMFORT 389
99 HYPERHIDROSIS 388
100 RENAL FAILURE 376
101 CHEST PAIN 375
102 INJECTION SITE INJURY 363
103 STRESS 359
104 HYPOAESTHESIA 353
105 PYREXIA 341
106 INFLUENZA 340
107 LOSS OF CONSCIOUSNESS 336
108 PANCREATITIS ACUTE 336
109 CARDIAC DISORDER 331
110 HEART RATE INCREASED 331
111 CONFUSIONAL STATE 327
112 MOBILITY DECREASED 325
113 DRUG INTERACTION 323
114 INJECTION SITE REACTION 317
115 NO ADVERSE EVENT 314
116 CHRONIC KIDNEY DISEASE 313
117 BLOOD GLUCOSE FLUCTUATION 304
118 LACTIC ACIDOSIS 301
119 HYPOTENSION 299
120 HYPERGLYCAEMIA 291
121 DIABETES MELLITUS 289
122 DYSGEUSIA 288
123 NEUROPATHY PERIPHERAL 284
124 CONDITION AGGRAVATED 283
125 POLLAKIURIA 283
126 CHOLELITHIASIS 277
127 ILEUS 277
128 PALPITATIONS 276
129 MYALGIA 275
130 DRUG INTOLERANCE 271
131 PARAESTHESIA 263
132 FUNGAL INFECTION 262
133 RENAL DISORDER 262
134 HUNGER 259
135 SEPSIS 254
136 RENAL IMPAIRMENT 253
137 DRY MOUTH 250
138 PANCREATIC CARCINOMA 250
139 ATRIAL FIBRILLATION 248
140 SWELLING 241
141 ACCIDENTAL EXPOSURE TO PRODUCT 235
142 ARTHRITIS 235
143 HYPOPHAGIA 235
144 DYSPHAGIA 234
145 INCREASED APPETITE 229
146 NEPHROLITHIASIS 225
147 SYNCOPE 225
148 NERVOUSNESS 224
149 SINUSITIS 224
150 LETHARGY 221
151 MUSCULAR WEAKNESS 219
152 BALANCE DISORDER 216
153 DISCOMFORT 216
154 NEOPLASM MALIGNANT 214
155 OROPHARYNGEAL PAIN 214
156 BLINDNESS 211
157 ERYTHEMA 209
158 BLOOD PRESSURE DECREASED 206
159 EATING DISORDER 204
160 DYSPHONIA 203
161 MIGRAINE 198
162 INFECTION 197
163 LIPASE INCREASED 195
164 CHILLS 193
165 GENERAL PHYSICAL HEALTH DETERIORATION 193
166 NECK PAIN 191
167 CONTUSION 190
168 CARDIAC FAILURE CONGESTIVE 187
169 VERTIGO 187
170 ANAEMIA 181
171 ASTHMA 181
172 BLOOD CREATININE INCREASED 181
173 JOINT SWELLING 173
174 METABOLIC ACIDOSIS 173
175 TASTE DISORDER 169
176 PRODUCT USE IN UNAPPROVED INDICATION 168
177 BURNING SENSATION 166
178 PSORIASIS 163
179 CARDIAC FAILURE 161
180 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 161
181 INFLUENZA LIKE ILLNESS 161
182 RETCHING 160
183 ROAD TRAFFIC ACCIDENT 159
184 PRODUCT USE ISSUE 158
185 DRY SKIN 157
186 EYE DISORDER 157
187 DEMENTIA 154
188 AMNESIA 153
189 BRONCHITIS 153
190 RASH PRURITIC 153
191 CELLULITIS 151
192 LIMB INJURY 151
193 CHEST DISCOMFORT 148
194 SLEEP DISORDER 147
195 INJECTION SITE IRRITATION 146
196 THROMBOSIS 146
197 INJECTION SITE INDURATION 144
198 EXPIRED PRODUCT ADMINISTERED 141
199 EUGLYCAEMIC DIABETIC KETOACIDOSIS 138
200 KETOACIDOSIS 138
201 TACHYCARDIA 138
202 DEPRESSED MOOD 136
203 DEVICE DIFFICULT TO USE 134
204 HOT FLUSH 134
205 BLOOD CHOLESTEROL INCREASED 132
206 INJECTION SITE DISCOLOURATION 132
207 EMOTIONAL DISTRESS 131
208 GASTRIC DISORDER 131
209 GASTROENTERITIS VIRAL 131
210 LIMB DISCOMFORT 131
211 EYE PAIN 130
212 SEIZURE 129
213 GASTRITIS 128
214 DYSURIA 127
215 INJECTION SITE WARMTH 127
216 FLUID RETENTION 126
217 THIRST 126
218 FREQUENT BOWEL MOVEMENTS 125
219 OEDEMA PERIPHERAL 125
220 GLYCOSYLATED HAEMOGLOBIN DECREASED 124
221 PANCREATIC DISORDER 124
222 HAEMORRHAGE 121
223 DIABETIC RETINOPATHY 119
224 RHEUMATOID ARTHRITIS 118
225 SWELLING FACE 118
226 INTENTIONAL PRODUCT MISUSE 117
227 THYROID MASS 117
228 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 116
229 BLOOD TRIGLYCERIDES INCREASED 115
230 BREAST CANCER 115
231 CHOLECYSTITIS 115
232 GASTROINTESTINAL PAIN 115
233 IRRITABILITY 115
234 MUSCULOSKELETAL STIFFNESS 115
235 HEPATIC ENZYME INCREASED 114
236 FEELING HOT 113
237 HYPERSOMNIA 112
238 ARTHROPATHY 111
239 DEVICE ISSUE 111
240 WRONG PATIENT RECEIVED PRODUCT 110
241 GLOMERULAR FILTRATION RATE DECREASED 109
242 SPEECH DISORDER 109
243 PRESYNCOPE 108
244 PRODUCT PRESCRIBING ERROR 108
245 THROAT IRRITATION 108
246 LIVER DISORDER 107
247 HAEMATOCHEZIA 106
248 MENTAL DISORDER 106
249 RHINORRHOEA 106
250 THERAPY INTERRUPTED 106
251 DYSSTASIA 103
252 GAIT INABILITY 103
253 MALNUTRITION 103
254 HAEMOGLOBIN DECREASED 102
255 HEPATIC STEATOSIS 101
256 DISTURBANCE IN ATTENTION 100
257 EYE HAEMORRHAGE 98
258 FLUSHING 98
259 HERPES ZOSTER 97
260 LOCALISED INFECTION 97
261 NASAL CONGESTION 97
262 PRODUCT DISPENSING ERROR 97
263 BACK DISORDER 96
264 HYPERKALAEMIA 96
265 RECTAL HAEMORRHAGE 96
266 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 96
267 SUICIDAL IDEATION 95
268 DRY EYE 94
269 COMA 93
270 HOSPITALISATION 93
271 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 93
272 INJECTION SITE NODULE 92
273 THYROID CANCER 92
274 VOMITING PROJECTILE 92
275 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 92
276 BLOOD POTASSIUM DECREASED 91
277 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 91
278 COLITIS 91
279 FEELING JITTERY 91
280 HEPATIC CIRRHOSIS 91
281 PULMONARY EMBOLISM 91
282 INJECTION SITE VESICLES 90
283 HICCUPS 89
284 OEDEMA 89
285 DRUG DOSE OMISSION BY DEVICE 88
286 TRANSIENT ISCHAEMIC ATTACK 88
287 ANAPHYLACTIC REACTION 87
288 BLOOD PRESSURE ABNORMAL 87
289 GALLBLADDER DISORDER 87
290 GASTRIC HYPOMOTILITY 87
291 MASS 86
292 THYROID DISORDER 86
293 FOOD CRAVING 85
294 PULMONARY OEDEMA 85
295 FOURNIER^S GANGRENE 84
296 ANGIOEDEMA 83
297 OSTEOARTHRITIS 83
298 HEAD INJURY 82
299 MUSCULOSKELETAL PAIN 82
300 PLATELET COUNT DECREASED 82
301 SKIN DISCOLOURATION 82
302 AGEUSIA 81
303 INTENTIONAL PRODUCT USE ISSUE 81
304 NECK MASS 81
305 SLEEP APNOEA SYNDROME 81
306 TINNITUS 81
307 ABDOMINAL PAIN LOWER 80
308 DIVERTICULITIS 80
309 EPISTAXIS 80
310 HERNIA 80
311 INFLAMMATION 80
312 MUSCULOSKELETAL DISCOMFORT 80
313 TYPE 2 DIABETES MELLITUS 80
314 UPPER RESPIRATORY TRACT INFECTION 80
315 APPETITE DISORDER 79
316 JOINT INJURY 79
317 PNEUMONIA ASPIRATION 79
318 THERAPEUTIC RESPONSE SHORTENED 79
319 AMYLASE INCREASED 78
320 BLINDNESS UNILATERAL 78
321 BLISTER 78
322 GLAUCOMA 78
323 LIP SWELLING 78
324 MATERNAL EXPOSURE DURING PREGNANCY 78
325 SKIN EXFOLIATION 78
326 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 78
327 INJECTION SITE HYPERSENSITIVITY 77
328 OXYGEN SATURATION DECREASED 77
329 VIRAL INFECTION 77
330 DIABETIC NEUROPATHY 76
331 IRRITABLE BOWEL SYNDROME 76
332 OVERWEIGHT 76
333 CARDIAC ARREST 75
334 ECZEMA 75
335 EYE SWELLING 75
336 SMALL INTESTINAL OBSTRUCTION 75
337 SURGERY 74
338 ANKLE FRACTURE 73
339 COLD SWEAT 73
340 COLITIS ULCERATIVE 73
341 FEELING COLD 73
342 SEPTIC SHOCK 73
343 ARRHYTHMIA 72
344 DEAFNESS 72
345 HALLUCINATION 72
346 LYMPHADENOPATHY 72
347 SKIN ULCER 72
348 PRODUCT DOSE OMISSION IN ERROR 71
349 THERAPEUTIC RESPONSE DECREASED 71
350 THINKING ABNORMAL 71
351 BOWEL MOVEMENT IRREGULARITY 70
352 EYE IRRITATION 70
353 CHROMATURIA 69
354 EARLY SATIETY 69
355 GOUT 69
356 INJURY 69
357 INSULIN RESISTANCE 69
358 KIDNEY INFECTION 69
359 NIGHT SWEATS 69
360 SEASONAL ALLERGY 69
361 SLUGGISHNESS 69
362 CYSTITIS 68
363 DECREASED ACTIVITY 67
364 DIABETIC METABOLIC DECOMPENSATION 67
365 HYPOKALAEMIA 67
366 INJECTION SITE COLDNESS 67
367 INTERVERTEBRAL DISC PROTRUSION 67
368 PRODUCTIVE COUGH 67
369 WRONG PRODUCT ADMINISTERED 67
370 GASTROINTESTINAL HAEMORRHAGE 66
371 MACULAR DEGENERATION 66
372 PANIC ATTACK 66
373 SWOLLEN TONGUE 66
374 UPPER LIMB FRACTURE 66
375 URINARY INCONTINENCE 66
376 ALANINE AMINOTRANSFERASE INCREASED 65
377 COGNITIVE DISORDER 65
378 GASTROENTERITIS 65
379 INCORRECT PRODUCT STORAGE 65
380 MENTAL IMPAIRMENT 65
381 PROCEDURAL PAIN 65
382 WHITE BLOOD CELL COUNT DECREASED 65
383 WHITE BLOOD CELL COUNT INCREASED 65
384 AGITATION 64
385 BLOOD POTASSIUM INCREASED 64
386 LUNG DISORDER 64
387 ANAL INCONTINENCE 63
388 HEART RATE DECREASED 63
389 LACRIMATION INCREASED 63
390 OSTEOMYELITIS 63
391 PSORIATIC ARTHROPATHY 63
392 THERAPY CESSATION 63
393 URINARY RETENTION 63
394 WOUND 63
395 INJECTION SITE SCAR 62
396 OCULAR HYPERAEMIA 62
397 RASH GENERALISED 62
398 ROTATOR CUFF SYNDROME 62
399 ILL-DEFINED DISORDER 61
400 INCORRECT DOSE ADMINISTERED BY DEVICE 61
401 SINUS DISORDER 61
402 BONE PAIN 60
403 DEVICE LEAKAGE 60
404 GASTROINTESTINAL SOUNDS ABNORMAL 60
405 HAEMATEMESIS 60
406 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60
407 RASH ERYTHEMATOUS 60
408 RETINOPATHY 60
409 UNEVALUABLE EVENT 60
410 DIPLOPIA 59
411 PRODUCT QUALITY ISSUE 59
412 DEMENTIA ALZHEIMER^S TYPE 58
413 MUSCLE ATROPHY 58
414 NEURALGIA 58
415 PANCREATIC CARCINOMA METASTATIC 58
416 THROMBOCYTOPENIA 58
417 CRYING 57
418 DEVICE MALFUNCTION 57
419 HYPONATRAEMIA 57
420 HYPOTHYROIDISM 57
421 NEUTROPENIA 57
422 VISUAL ACUITY REDUCED 57
423 ASPARTATE AMINOTRANSFERASE INCREASED 56
424 CEREBRAL INFARCTION 56
425 IMPAIRED HEALING 56
426 SHOCK 56
427 BRAIN FOG 55
428 DYSPNOEA EXERTIONAL 55
429 GALLBLADDER INJURY 55
430 HEAD DISCOMFORT 55
431 INJECTION SITE PARAESTHESIA 55
432 PRURITUS GENERALISED 55
433 RENAL PAIN 55
434 ANGINA PECTORIS 54
435 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 54
436 POOR QUALITY SLEEP 54
437 SCIATICA 54
438 THERAPEUTIC PRODUCT EFFECT DECREASED 54
439 ACCIDENT 53
440 COVID-19 PNEUMONIA 53
441 FLUID INTAKE REDUCED 53
442 NERVE INJURY 53
443 NODULE 53
444 STAPHYLOCOCCAL INFECTION 53
445 ACUTE MYOCARDIAL INFARCTION 52
446 RENAL INJURY 52
447 RESPIRATORY FAILURE 52
448 SKIN DISORDER 52
449 TREATMENT NONCOMPLIANCE 52
450 FAECES DISCOLOURED 51
451 HYPERCHLORHYDRIA 51
452 LIVER FUNCTION TEST INCREASED 51
453 SCAR 51
454 SUICIDE ATTEMPT 51
455 TUBULOINTERSTITIAL NEPHRITIS 51
456 WRONG DOSE 51
457 ADVERSE DRUG REACTION 50
458 BLOOD URINE PRESENT 50
459 CARPAL TUNNEL SYNDROME 50
460 EYE PRURITUS 50
461 FEAR 50
462 FOOT FRACTURE 50
463 OBESITY 50
464 OROPHARYNGEAL DISCOMFORT 50
465 RETINAL DETACHMENT 50
466 ADVERSE EVENT 49
467 CORONARY ARTERY DISEASE 49
468 DYSKINESIA 49
469 FOOD POISONING 49
470 MULTIPLE SCLEROSIS 49
471 NEEDLE ISSUE 49
472 PARKINSON^S DISEASE 49
473 SCRATCH 49
474 DRUG LEVEL INCREASED 48
475 GANGRENE 48
476 PAROSMIA 48
477 TOXICITY TO VARIOUS AGENTS 48
478 C-REACTIVE PROTEIN INCREASED 47
479 EAR INFECTION 47
480 ERECTILE DYSFUNCTION 47
481 PROSTATE CANCER 47
482 RESTLESSNESS 47
483 RHABDOMYOLYSIS 47
484 THROAT TIGHTNESS 47
485 DERMATITIS ATOPIC 46
486 END STAGE RENAL DISEASE 46
487 FIBROMYALGIA 46
488 HIP FRACTURE 46
489 INTENTIONAL DOSE OMISSION 46
490 ISCHAEMIC STROKE 46
491 LOWER LIMB FRACTURE 46
492 MOOD ALTERED 46
493 STOMATITIS 46
494 BACK INJURY 45
495 CEREBRAL HAEMORRHAGE 45
496 INJECTION SITE EXTRAVASATION 45
497 MOVEMENT DISORDER 45
498 OPTIC ISCHAEMIC NEUROPATHY 45
499 RIB FRACTURE 45
500 CEREBRAL DISORDER 44
501 COLON CANCER 44
502 CORONARY ARTERY OCCLUSION 44
503 DEEP VEIN THROMBOSIS 44
504 DISORIENTATION 44
505 MUSCULOSKELETAL DISORDER 44
506 RASH MACULAR 44
507 TREATMENT FAILURE 44
508 VAGINAL HAEMORRHAGE 44
509 WHEEZING 44
510 ANGER 43
511 ATRIOVENTRICULAR BLOCK 43
512 BRADYCARDIA 43
513 INCORRECT ROUTE OF DRUG ADMINISTRATION 43
514 INJECTION SITE INDENTATION 43
515 LUNG NEOPLASM MALIGNANT 43
516 NOCTURIA 43
517 PHARYNGEAL SWELLING 43
518 POLYURIA 43
519 ACUTE RESPIRATORY FAILURE 42
520 FEAR OF INJECTION 42
521 SNEEZING 42
522 VITREOUS FLOATERS 42
523 WEIGHT FLUCTUATION 42
524 ACNE 41
525 APHASIA 41
526 CARDIOVASCULAR DISORDER 41
527 CHOKING 41
528 CHOLESTASIS 41
529 COLITIS ISCHAEMIC 41
530 DIABETIC FOOT 41
531 DRUG-INDUCED LIVER INJURY 41
532 MOOD SWINGS 41
533 NERVE COMPRESSION 41
534 BLOOD MAGNESIUM DECREASED 40
535 DYSARTHRIA 40
536 GAMMA-GLUTAMYLTRANSFERASE INCREASED 40
537 HYPOKINESIA 40
538 INJECTION SITE HAEMATOMA 40
539 INJECTION SITE INFLAMMATION 40
540 URINE OUTPUT DECREASED 40
541 BLOOD UREA INCREASED 39
542 CARDIO-RESPIRATORY ARREST 39
543 CHOLECYSTITIS ACUTE 39
544 IMMUNE SYSTEM DISORDER 39
545 INTERSTITIAL LUNG DISEASE 39
546 PLEURAL EFFUSION 39
547 URINE ODOUR ABNORMAL 39
548 ABNORMAL LOSS OF WEIGHT 38
549 HAEMATURIA 38
550 INSURANCE ISSUE 38
551 LYMPHOMA 38
552 MUSCLE TIGHTNESS 38
553 POST PROCEDURAL COMPLICATION 38
554 BONE DISORDER 37
555 HEPATIC FUNCTION ABNORMAL 37
556 MUSCLE TWITCHING 37
557 PHOTOPHOBIA 37
558 POST-TRAUMATIC STRESS DISORDER 37
559 RESPIRATORY DISORDER 37
560 SKIN BURNING SENSATION 37
561 SPINAL FRACTURE 37
562 ACCIDENT AT WORK 36
563 ALTERED STATE OF CONSCIOUSNESS 36
564 CROHN^S DISEASE 36
565 FACE OEDEMA 36
566 HEPATITIS 36
567 HYPERPHAGIA 36
568 MULTIPLE SCLEROSIS RELAPSE 36
569 PANCREATITIS NECROTISING 36
570 PRODUCT ADMINISTRATION ERROR 36
571 PRODUCT ADMINISTRATION INTERRUPTED 36
572 BACTERIAL INFECTION 35
573 BIPOLAR DISORDER 35
574 BLOOD PRESSURE FLUCTUATION 35
575 DIABETIC COMPLICATION 35
576 HEART RATE IRREGULAR 35
577 LIVER INJURY 35
578 NERVOUS SYSTEM DISORDER 35
579 OSTEOPOROSIS 35
580 PANCREATIC ENZYMES INCREASED 35
581 PERIPHERAL COLDNESS 35
582 SENSATION OF FOREIGN BODY 35
583 SKIN HAEMORRHAGE 35
584 ABNORMAL FAECES 34
585 ABSCESS 34
586 ARTERIAL OCCLUSIVE DISEASE 34
587 BRAIN NEOPLASM 34
588 CYST 34
589 DRUG EFFECT LESS THAN EXPECTED 34
590 FEMUR FRACTURE 34
591 HEPATIC CYTOLYSIS 34
592 INJECTION SITE HYPOAESTHESIA 34
593 JAUNDICE 34
594 LARYNGITIS 34
595 MIDDLE INSOMNIA 34
596 PALLOR 34
597 SKIN LACERATION 34
598 ABNORMAL BEHAVIOUR 33
599 BLADDER CANCER 33
600 BLOOD LACTIC ACID INCREASED 33
601 DEVICE USE ERROR 33
602 EXPOSURE VIA SKIN CONTACT 33
603 GLUCOSE URINE PRESENT 33
604 HEPATIC CANCER 33
605 HIATUS HERNIA 33
606 INFREQUENT BOWEL MOVEMENTS 33
607 INTENTIONAL OVERDOSE 33
608 JOINT STIFFNESS 33
609 MULTIPLE ALLERGIES 33
610 ORAL PAIN 33
611 PERICARDIAL EFFUSION 33
612 PRODUCT COMMUNICATION ISSUE 33
613 SKIN FISSURES 33
614 SKIN IRRITATION 33
615 ULCER 33
616 ADRENAL INSUFFICIENCY 32
617 BLOOD PRESSURE SYSTOLIC INCREASED 32
618 DISEASE RECURRENCE 32
619 EAR PAIN 32
620 FAECALOMA 32
621 MEDICATION ERROR 32
622 OCULAR DISCOMFORT 32
623 PANCYTOPENIA 32
624 PHOTOSENSITIVITY REACTION 32
625 PULMONARY CONGESTION 32
626 SINUS CONGESTION 32
627 THIRST DECREASED 32
628 VITAMIN D DEFICIENCY 32
629 CARDIAC FLUTTER 31
630 CYCLIC VOMITING SYNDROME 31
631 GASTRIC ULCER 31
632 HYPOAESTHESIA ORAL 31
633 HYPOXIA 31
634 INFUSION RELATED REACTION 31
635 LIGAMENT SPRAIN 31
636 MICTURITION URGENCY 31
637 NECROTISING FASCIITIS 31
638 PARAESTHESIA ORAL 31
639 PEMPHIGOID 31
640 POST PROCEDURAL INFECTION 31
641 RASH PAPULAR 31
642 REGURGITATION 31
643 TOOTH DISORDER 31
644 ANHEDONIA 30
645 APHONIA 30
646 ASCITES 30
647 BLADDER DISORDER 30
648 DISEASE PROGRESSION 30
649 DIZZINESS POSTURAL 30
650 DRUG DISPENSING ERROR 30
651 EYE INFECTION 30
652 FAECES HARD 30
653 FRACTURE 30
654 GENERALISED OEDEMA 30
655 HAEMORRHOIDS 30
656 INCORRECT PRODUCT ADMINISTRATION DURATION 30
657 INTERCEPTED PRODUCT DISPENSING ERROR 30
658 MUSCULOSKELETAL CHEST PAIN 30
659 OBSTRUCTIVE PANCREATITIS 30
660 ORTHOSTATIC HYPOTENSION 30
661 PAIN IN JAW 30
662 PANCREATITIS CHRONIC 30
663 RENAL CANCER 30
664 SPINAL STENOSIS 30
665 TOOTH FRACTURE 30
666 BLOOD CALCIUM INCREASED 29
667 CARDIOGENIC SHOCK 29
668 CHOLECYSTECTOMY 29
669 DRY THROAT 29
670 ELECTROLYTE IMBALANCE 29
671 GASTRIC CANCER 29
672 HEPATIC ENCEPHALOPATHY 29
673 HYPERLIPIDAEMIA 29
674 LIVER FUNCTION TEST ABNORMAL 29
675 MALIGNANT NEOPLASM PROGRESSION 29
676 MUSCLE STRAIN 29
677 NEPHROPATHY 29
678 NIGHTMARE 29
679 PRODUCT AVAILABILITY ISSUE 29
680 THYROID NEOPLASM 29
681 AGGRESSION 28
682 ASPIRATION 28
683 BLOOD CHOLESTEROL ABNORMAL 28
684 BLOOD SODIUM DECREASED 28
685 CHOLANGITIS 28
686 DENTAL CARIES 28
687 DERMATITIS ALLERGIC 28
688 ILEUS PARALYTIC 28
689 INFUSION SITE PAIN 28
690 KNEE ARTHROPLASTY 28
691 METABOLIC DISORDER 28
692 NEPHROGENIC ANAEMIA 28
693 PLASMA CELL MYELOMA 28
694 SKIN LESION 28
695 TENDERNESS 28
696 ABSCESS LIMB 27
697 APPENDICITIS 27
698 AUTOIMMUNE DISORDER 27
699 BLINDNESS TRANSIENT 27
700 BLOOD ALKALINE PHOSPHATASE INCREASED 27
701 BODY MASS INDEX INCREASED 27
702 CONCUSSION 27
703 DEVICE DEFECTIVE 27
704 DRUG ADMINISTERED AT INAPPROPRIATE SITE 27
705 FLANK PAIN 27
706 FRUSTRATION TOLERANCE DECREASED 27
707 FUNCTIONAL GASTROINTESTINAL DISORDER 27
708 GASTROINTESTINAL MOTILITY DISORDER 27
709 HYPOGLYCAEMIC COMA 27
710 INCORRECT PRODUCT FORMULATION ADMINISTERED 27
711 INTERVERTEBRAL DISC DEGENERATION 27
712 MENISCUS INJURY 27
713 ORAL DISCOMFORT 27
714 PULMONARY MASS 27
715 RASH MACULO-PAPULAR 27
716 RENAL FUNCTION TEST ABNORMAL 27
717 RETINAL HAEMORRHAGE 27
718 SKIN CANCER 27
719 TENDON RUPTURE 27
720 THERAPY NON-RESPONDER 27
721 BLOOD IRON DECREASED 26
722 DEPRESSED LEVEL OF CONSCIOUSNESS 26
723 DEVICE USE ISSUE 26
724 DRUG EFFECT DECREASED 26
725 EAR DISCOMFORT 26
726 EMOTIONAL DISORDER 26
727 EOSINOPHILIA 26
728 GASTROINTESTINAL INFECTION 26
729 HAEMATOMA 26
730 LABORATORY TEST ABNORMAL 26
731 MIOSIS 26
732 PRESCRIBED OVERDOSE 26
733 RENAL CYST 26
734 RESPIRATORY TRACT INFECTION 26
735 SUBDURAL HAEMATOMA 26
736 TENDONITIS 26
737 THERAPEUTIC RESPONSE UNEXPECTED 26
738 VULVOVAGINAL MYCOTIC INFECTION 26
739 VULVOVAGINAL PRURITUS 26
740 BLOOD BILIRUBIN INCREASED 25
741 BRAIN INJURY 25
742 BURSITIS 25
743 CORONAVIRUS INFECTION 25
744 DEVICE DELIVERY SYSTEM ISSUE 25
745 FOETAL EXPOSURE DURING PREGNANCY 25
746 GASTRIC DILATATION 25
747 HEMIPLEGIA 25
748 IMPAIRED QUALITY OF LIFE 25
749 INTERCEPTED PRODUCT SELECTION ERROR 25
750 INTERNAL HAEMORRHAGE 25
751 INTESTINAL ISCHAEMIA 25
752 KETOSIS 25
753 LYMPHOEDEMA 25
754 MELAENA 25
755 METASTASES TO LIVER 25
756 MYASTHENIA GRAVIS 25
757 PRODUCT SUBSTITUTION ISSUE 25
758 SARS-COV-2 TEST POSITIVE 25
759 SENSITIVE SKIN 25
760 TRANSAMINASES INCREASED 25
761 ABDOMINAL RIGIDITY 24
762 ANAL ABSCESS 24
763 ARTHROPOD BITE 24
764 BREATH ODOUR 24
765 DRUG PRESCRIBING ERROR 24
766 HYPOVOLAEMIA 24
767 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 24
768 PAIN OF SKIN 24
769 PARALYSIS 24
770 PHARYNGITIS STREPTOCOCCAL 24
771 PNEUMONITIS 24
772 SKIN MASS 24
773 SPINAL DISORDER 24
774 SPINAL OPERATION 24
775 SPINAL PAIN 24
776 SYSTEMIC LUPUS ERYTHEMATOSUS 24
777 ABNORMAL DREAMS 23
778 ADENOCARCINOMA PANCREAS 23
779 BASAL CELL CARCINOMA 23
780 BLOOD TEST ABNORMAL 23
781 FOOD AVERSION 23
782 HYPERTRIGLYCERIDAEMIA 23
783 HYPOMAGNESAEMIA 23
784 INCONTINENCE 23
785 PANCREATIC CYST 23
786 QUALITY OF LIFE DECREASED 23
787 SPLENOMEGALY 23
788 SYSTEMIC INFECTION 23
789 TOOTH ABSCESS 23
790 TOOTHACHE 23
791 URINE KETONE BODY PRESENT 23
792 ANAPHYLACTIC SHOCK 22
793 ARTERIOSCLEROSIS 22
794 CLOSTRIDIUM DIFFICILE INFECTION 22
795 CONTRAINDICATED PRODUCT ADMINISTERED 22
796 DIARRHOEA HAEMORRHAGIC 22
797 DYSGRAPHIA 22
798 EPIGASTRIC DISCOMFORT 22
799 FEBRILE NEUTROPENIA 22
800 HEPATOCELLULAR INJURY 22
801 HEPATOMEGALY 22
802 LICHEN PLANUS 22
803 NEOPLASM 22
804 PANCREATIC FAILURE 22
805 POISONING DELIBERATE 22
806 POLYP 22
807 PRODUCT MONITORING ERROR 22
808 PRODUCT PHYSICAL ISSUE 22
809 RED BLOOD CELL COUNT DECREASED 22
810 SKIN INFECTION 22
811 SKIN ODOUR ABNORMAL 22
812 SKIN REACTION 22
813 UPPER-AIRWAY COUGH SYNDROME 22
814 ACIDOSIS 21
815 BILE DUCT STONE 21
816 BILIARY COLIC 21
817 DEFAECATION URGENCY 21
818 DELIRIUM 21
819 DEVICE MECHANICAL ISSUE 21
820 DIABETIC COMA 21
821 EJECTION FRACTION DECREASED 21
822 GASTROINTESTINAL INFLAMMATION 21
823 GOITRE 21
824 HAIR GROWTH ABNORMAL 21
825 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 21
826 INJECTION SITE DISCHARGE 21
827 MACULAR OEDEMA 21
828 MEDULLARY THYROID CANCER 21
829 NEUTROPHIL COUNT INCREASED 21
830 PRODUCT USE COMPLAINT 21
831 SECRETION DISCHARGE 21
832 APATHY 20
833 BONE DENSITY DECREASED 20
834 DECUBITUS ULCER 20
835 EPILEPSY 20
836 HAEMOGLOBIN INCREASED 20
837 HYPERLIPASAEMIA 20
838 INITIAL INSOMNIA 20
839 KNEE OPERATION 20
840 LOWER RESPIRATORY TRACT INFECTION 20
841 PAPILLARY THYROID CANCER 20
842 POLYDIPSIA 20
843 PRODUCT PREPARATION ERROR 20
844 RED BLOOD CELL SEDIMENTATION RATE INCREASED 20
845 SCAB 20
846 THERAPY CHANGE 20
847 WRIST FRACTURE 20
848 ACUTE CORONARY SYNDROME 19
849 ACUTE RESPIRATORY DISTRESS SYNDROME 19
850 BLOOD CREATINE INCREASED 19
851 CANDIDA INFECTION 19
852 CARDIAC FAILURE ACUTE 19
853 CARDIAC MURMUR 19
854 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 19
855 DERMATITIS 19
856 DERMATITIS CONTACT 19
857 FAT TISSUE INCREASED 19
858 FOOD ALLERGY 19
859 GRIP STRENGTH DECREASED 19
860 HYPERVOLAEMIA 19
861 HYPOCALCAEMIA 19
862 IMMUNE-MEDIATED MYOSITIS 19
863 INCORRECT DOSAGE ADMINISTERED 19
864 MOUTH ULCERATION 19
865 MYOCARDIAL ISCHAEMIA 19
866 NECK INJURY 19
867 ORAL HERPES 19
868 PRODUCT DISTRIBUTION ISSUE 19
869 PROTEINURIA 19
870 PULMONARY HYPERTENSION 19
871 PYELONEPHRITIS 19
872 RESPIRATORY DISTRESS 19
873 SALIVARY HYPERSECRETION 19
874 TARDIVE DYSKINESIA 19
875 TYPE 1 DIABETES MELLITUS 19
876 UROSEPSIS 19
877 VASCULITIS 19
878 ABDOMINAL TENDERNESS 18
879 BLOOD THYROID STIMULATING HORMONE INCREASED 18
880 CHOLECYSTITIS INFECTIVE 18
881 ELECTROCARDIOGRAM QT PROLONGED 18
882 FEBRILE BONE MARROW APLASIA 18
883 GASTROINTESTINAL INJURY 18
884 GENITAL ABSCESS 18
885 HAEMATOCRIT DECREASED 18
886 HAEMORRHAGIC STROKE 18
887 HAND FRACTURE 18
888 HEART RATE ABNORMAL 18
889 HYPERPARATHYROIDISM SECONDARY 18
890 INJECTION SITE INFECTION 18
891 LARGE INTESTINE POLYP 18
892 LEUKOCYTOSIS 18
893 MARASMUS 18
894 MOUTH SWELLING 18
895 NEOPLASM PROGRESSION 18
896 RESTLESS LEGS SYNDROME 18
897 SENSORY LOSS 18
898 SINUS TACHYCARDIA 18
899 SKIN HYPERPIGMENTATION 18
900 SUPRAVENTRICULAR TACHYCARDIA 18
901 SUSPECTED COVID-19 18
902 TOE AMPUTATION 18
903 UPPER GASTROINTESTINAL HAEMORRHAGE 18
904 URINE OUTPUT INCREASED 18
905 UTERINE CANCER 18
906 VAGINAL INFECTION 18
907 WITHDRAWAL SYNDROME 18
908 WOUND INFECTION 18
909 ABDOMINAL MASS 17
910 AUTOIMMUNE HEPATITIS 17
911 BLOOD CALCIUM DECREASED 17
912 BODY TEMPERATURE DECREASED 17
913 COELIAC DISEASE 17
914 COMPLICATION ASSOCIATED WITH DEVICE 17
915 DRUG DEPENDENCE 17
916 DYSLIPIDAEMIA 17
917 ENCEPHALOPATHY 17
918 EXPOSURE DURING PREGNANCY 17
919 FACIAL PARALYSIS 17
920 FAECES SOFT 17
921 FOOT DEFORMITY 17
922 GLOSSODYNIA 17
923 HAEMOLYTIC ANAEMIA 17
924 HALLUCINATION, VISUAL 17
925 HYPERCALCAEMIA 17
926 HYPOGLYCAEMIC UNCONSCIOUSNESS 17
927 INABILITY TO AFFORD MEDICATION 17
928 INTERVERTEBRAL DISC DISORDER 17
929 INTRAOCULAR PRESSURE INCREASED 17
930 ORAL CANDIDIASIS 17
931 PANCREATIC MASS 17
932 PERIPHERAL VASCULAR DISORDER 17
933 PORTAL HYPERTENSION 17
934 POSTOPERATIVE WOUND INFECTION 17
935 PRODUCT ODOUR ABNORMAL 17
936 PRODUCT STORAGE ISSUE 17
937 PSYCHOTIC DISORDER 17
938 TOOTH INFECTION 17
939 TOOTH LOSS 17
940 TRIGGER FINGER 17
941 UNRESPONSIVE TO STIMULI 17
942 VITAMIN D DECREASED 17
943 VULVOVAGINAL BURNING SENSATION 17
944 WEIGHT ABNORMAL 17
945 APPLICATION SITE PAIN 16
946 BLOOD KETONE BODY INCREASED 16
947 BLOOD TESTOSTERONE DECREASED 16
948 BRADYKINESIA 16
949 CARDIAC OPERATION 16
950 COMPLETED SUICIDE 16
951 DRUG RESISTANCE 16
952 EXOSTOSIS 16
953 EXTRASYSTOLES 16
954 FULL BLOOD COUNT DECREASED 16
955 GINGIVAL BLEEDING 16
956 HAEMOPTYSIS 16
957 HEMIPARESIS 16
958 HEPATIC FAILURE 16
959 HEREDITARY ANGIOEDEMA 16
960 HERPES VIRUS INFECTION 16
961 IMPAIRED WORK ABILITY 16
962 INCREASED TENDENCY TO BRUISE 16
963 IRON DEFICIENCY ANAEMIA 16
964 JOINT DISLOCATION 16
965 LEUKAEMIA 16
966 LOW DENSITY LIPOPROTEIN INCREASED 16
967 LYMPHOCYTE COUNT DECREASED 16
968 MUSCLE DISORDER 16
969 OBSTRUCTIVE SLEEP APNOEA SYNDROME 16
970 OESOPHAGITIS 16
971 OLIGURIA 16
972 PANIC DISORDER 16
973 PERONEAL NERVE PALSY 16
974 PHARYNGEAL OEDEMA 16
975 PHOTOPSIA 16
976 PRE-EXISTING CONDITION IMPROVED 16
977 PRODUCT PRESCRIBING ISSUE 16
978 RASH VESICULAR 16
979 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16
980 SQUAMOUS CELL CARCINOMA 16
981 TACHYPNOEA 16
982 URINARY TRACT DISORDER 16
983 URINE ABNORMALITY 16
984 WEIGHT LOSS POOR 16
985 WRONG PATIENT RECEIVED MEDICATION 16
986 ACUTE HEPATIC FAILURE 15
987 ANOSMIA 15
988 B-CELL LYMPHOMA 15
989 BENIGN NEOPLASM OF THYROID GLAND 15
990 BLOOD CREATINE PHOSPHOKINASE INCREASED 15
991 BLOOD DISORDER 15
992 BLOOD PRESSURE DIASTOLIC INCREASED 15
993 CONJUNCTIVITIS 15
994 DELUSION 15
995 DIABETIC KETOSIS 15
996 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15
997 DRUG WITHDRAWAL SYNDROME 15
998 ECONOMIC PROBLEM 15
999 ESCHERICHIA URINARY TRACT INFECTION 15